JNJ-2113

Johnson & Johnson reports topline outcomes from trial of icotrokinra for psoriasis
Clinical Trials Arena
Tue, 11/19/24 - 11:00 am
JNJ
clinical trials
JNJ-2113
psoriasis
J&J Gets Phase II Win for First Targeted Oral Peptide in Plaque Psoriasis
BioSpace
Mon, 03/11/24 - 12:00 pm
JNJ
clinical trials
JNJ-2113
psoriasis
Johnson & Johnson reports data from Phase II plaque psoriasis trial
Clinical Trials Arena
Thu, 02/8/24 - 11:14 am
JNJ
clinical trials
psoriasis
JNJ-2113
Janssen’s trial of plaque psoriasis therapy meets endpoints
Clinical Trials Arena
Wed, 07/5/23 - 10:18 am
Janssen
JNJ
clinical trials
JNJ-2113
plaque psoriasis